Relay's targeted cancer drug could be safer than its competitors. Is it more effective?
Bio Pharma Dive
OCTOBER 8, 2021
Initial study results for Relay's experimental treatment offer some support for the biotech's protein motion technology, but raise some questions, too.
Let's personalize your content